With a distinguished career in health care spanning more than thirty years, Jim is a Founder and Managing Partner of Tyree & D’Angelo Partners (TDP), a private equity firm focused on investments in promising, underperforming businesses in the lower-middle market.
Prior to founding TDP in 2012, Jim had an outstanding 15 year career at Abbott, holding executive positions in its pharmaceutical and nutrition businesses. Jim was involved in many of the company’s major acquisitions and was responsible for the restructuring of TAP, Abbott’s joint venture with Takeda Chemicals of Japan. Jim served as Executive Vice President, Pharmaceutical Products, Abbott’s largest business, and was also directly responsible for establishing and managing Abbott Global Nutrition, Abbott’s second largest operating division. Jim also served as President of Abbott Biotech Ventures. Prior to his career at Abbott, Jim was President of Sugen, Inc., a biotech company focused on oncology, and held management positions at Bristol-Myers Squibb and Pfizer.
Jim currently serves or has served as an independent director of a number of privately and publicly held companies. He is also a member of The Council of Advisors at the University of Chicago Graduate School of Business (Booth). He earned his MBA from the Kelley School of Business at Indiana University, as well as two bachelor degrees in psychology and forensic studies from Indiana University.